Dosing our first patient in the VAN-2401 phase 1 trial is an important milestone in the advancement of KH658 by exploring the ...

Scientists enhance eye imaging with AI, achieving high-resolution views of retinal cells, potentially revolutionizing disease ...

Investigators from the Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, led by Ying Zhu, MD, PhD, who studied the ocular effects of repeated intravitreal ...

The OcuMet Beacon is a proprietary, noninvasive tool for assessing retinal health. The company said it will be available on the US market for use in clinics and healthcare institutions. The US Food ...

A panelist discusses how a woman aged 77 years with bilateral neovascular age-related macular degeneration (nAMD) demonstrated different responses to treatments between her eyes, showing a superior ...

Lukas Scheibler, PhD, has been appointed as chief research and development officer and Graham Cooper as chief financial officer of Tavo Biotherapeutics, the company recently announced. 1 “I am ...

A panelist discusses how a man aged 79 years with long-duration diabetes and treatment-naive diabetic macular edema (DME) responded well to aflibercept 8-mg therapy, progressing from 4-week loading ...

Retina World Congress 2025 is set to take place in Fort Lauderdale, Florida on May 8 through May 11, 2025. This meeting brings together retina specialists from around the globe to discuss research ...

The 2025 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting will take place May 4-8, 2025, in Salt Lake City, Utah. This meeting will feature presenter and researcher from ...

Prevent Blindness has declared May the second annual inherited retinal disease and genetic testing month, offering free resources on education and other awareness efforts. Offering a variety of free ...